Outer Biosciences Inc

MALDEN, MA · CIK 0002138797 · Biotech

Perfusion bioreactor platform keeping full-thickness human skin viable for up to four weeks, paired with machine learning models for compound screening

outerbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$23M
1 Form D · Aug 2026
2 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$23,291,523
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3266NIGHTSTAR BIOTECHNOLOGIES, INC——
3267ROCK IMMUNE LLC——
3268PROBIOME THERAPEUTICS, INC.——
3269Outer Biosciences Inc—$23M
3270Prelenia——
3271Ophysio Inc.——
3272ONCOC4, INC.—$50M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.